Clinical Trials Logo

Clinical Trial Summary

The ARCH is a controlled trial with a sequential design and with a prospective, randomized, open-label, blinded-endpoint (PROBE) methodology. The objective is to compare the efficacy and tolerance (net benefit) of two antithrombotic strategies in patients with atherothrombosis of the aortic arch and a recent (less than 6 months) cerebral or peripheral embolic event.

Hypothesis:

The association of clopidogrel 75 mg/d plus aspirin 75 mg/d is 25% more effective than an oral anticoagulant (target International Normalized Ratio [INR] 2 to 3) in preventing brain infarction, brain hemorrhage, myocardial infarction, peripheral embolism, and vascular death.


Clinical Trial Description

Patients with Transient Ischemic attack or brain infarction of unknown cause (no ipsilateral internal carotid artery origin stenosis greater than 70%, no ipsilateral severe intracranial stenosis of an artery supplying the infarcted area, no definite cardiac source of embolism) in the preceding 6 months and atherosclerotic plaques.

≥ 4 mm in the aortic arch, or patients with a peripheral event (e.g. renal infarct) in the preceding 6 months and plaque ≥ 4 mm in the thoracic aorta above the origin of the embolized artery. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00235248
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact
Status Completed
Phase Phase 3
Start date February 2002
Completion date July 2012

See also
  Status Clinical Trial Phase
Recruiting NCT00859885 - International PFO Consortium N/A
Not yet recruiting NCT03605355 - Feasibility Study on the Medical and Economic Consequences of Outpatient Management of TIAs and Minor Strokes
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Completed NCT04078737 - Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II Phase 3
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Recruiting NCT01954329 - Markers in the Diagnosis of TIA N/A
Completed NCT02011256 - Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack N/A
Completed NCT01918891 - Center for Stroke Disparities Solution - Community Transitions Intervention N/A
Recruiting NCT01526824 - Lovaza's Effect on Clopidogrel in a Neuro Population Phase 0
Completed NCT01020851 - The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke Trial N/A
Completed NCT00597974 - Neurological Outcome With Carotid Artery Stenting N/A
Completed NCT00211731 - Preventing Recurrent Stroke in Minority Populations N/A
Active, not recruiting NCT03635749 - Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Phase 3
Completed NCT03153020 - Determinants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the Rhône
Recruiting NCT04075500 - Optimal Detection of Atrial Fibrillation in TIA N/A
Recruiting NCT06091319 - Florbetaben for Imaging of Vascular Amyloid
Completed NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt N/A
Completed NCT00885456 - Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT Phase 2
Completed NCT05620966 - EEG to Diagnose TIA and Stroke